{"count": 96, "results": [{"_id": "37509614", "pmid": 37509614, "pmcid": "PMC10377707", "title": "Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients", "journal": "Biomedicines", "authors": ["Rastoder E", "Sivapalan P", "Eklöf J", "Achir Alispahic I", "Jordan AS", "Laursen CB", "Vestbo J", "Jenkins C", "Nielsen R", "Bakke P", "Fernandez-Romero G", "Modin D", "Johansen N", "Davidovski FS", "Biering-Sørensen T", "Carlsen J", "Jensen JUS"], "date": "2023-07-12T00:00:00Z", "doi": "10.3390/biomedicines11071974", "meta_date_publication": "2023 Jul 12", "meta_volume": "11", "meta_issue": "7", "meta_pages": "", "score": 50296.18, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ seems to be a safe first choice for the treatment of @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@arterial hypertension@@@ in @DISEASE_Pulmonary_Disease_Chronic_Obstructive @DISEASE_MESH:D029424 @@@COPD@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Rastoder E, Sivapalan P, Eklöf J, Achir Alispahic I, Jordan AS, Laursen CB, Vestbo J, Jenkins C, Nielsen R, Bakke P, Fernandez-Romero G, Modin D, Johansen N, Davidovski FS, Biering-Sørensen T, Carlsen J, Jensen JUS. Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients Biomedicines. 2023 Jul 12;11(7):. PMID: 37509614", "BibTeX": "@article{37509614, title={Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients}, author={Rastoder E and Sivapalan P and Eklöf J and Achir Alispahic I and Jordan AS and Laursen CB and Vestbo J and Jenkins C and Nielsen R and Bakke P and Fernandez-Romero G and Modin D and Johansen N and Davidovski FS and Biering-Sørensen T and Carlsen J and Jensen JUS}, journal={Biomedicines}, volume={11}, number={7}}"}}, {"_id": "38112360", "pmid": 38112360, "title": "S-AMLODIPINE AS A MODERN EFFECTIVE ANTIHYPERTENSIVE AND AN ANTIANGINAL AGENT.", "journal": "Wiad Lek", "authors": ["Chopei IV", "Chubirko KI", "Bychko MV", "Hechko MM", "Kedyk AV", "Kogutych II"], "date": "2023-01-01T00:00:00Z", "doi": "10.36740/WLek202311114", "meta_date_publication": "2023", "meta_volume": "76", "meta_issue": "11", "meta_pages": "2429-2434", "score": 50272.336, "text_hl": "RESULTS: Results: This study shows the high clinical effectiveness of the use of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@S-amlodipine@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@arterial hypertension@@@ associated with @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@coronary artery disease@@@. ", "citations": {"NLM": "Chopei IV, Chubirko KI, Bychko MV, Hechko MM, Kedyk AV, Kogutych II. S-AMLODIPINE AS A MODERN EFFECTIVE ANTIHYPERTENSIVE AND AN ANTIANGINAL AGENT. Wiad Lek. 2023;76(11):2429-2434. PMID: 38112360", "BibTeX": "@article{38112360, title={S-AMLODIPINE AS A MODERN EFFECTIVE ANTIHYPERTENSIVE AND AN ANTIANGINAL AGENT.}, author={Chopei IV and Chubirko KI and Bychko MV and Hechko MM and Kedyk AV and Kogutych II}, journal={Wiad Lek}, volume={76}, number={11}, pages={2429-2434}}"}}, {"_id": "39898751", "pmid": 39898751, "title": "[Combination therapy in arterial hypertension: how to personalize treatment].", "journal": "G Ital Cardiol (Rome)", "authors": ["Bacca A", "Taddei S"], "date": "2025-01-01T00:00:00Z", "doi": "10.1714/4425.44227", "meta_date_publication": "2025 Jan", "meta_volume": "26", "meta_issue": "1 Suppl 2", "meta_pages": "e23-e31", "score": 50270.98, "text_hl": "Therefore, the combinations of @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ represent a therapeutic opportunity of primary importance as they combine the ACE-inhibitor, AT1 antagonist and the calcium channel blocker with the best documentation of efficacy in randomized controlled trials.In conclusion, the support of the scientific literature indicates that the rational use of these combinations can certainly represent an optimal choice for the treatment of @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@arterial hypertension@@@ according to the best criteria of therapeutic appropriateness.", "citations": {"NLM": "Bacca A, Taddei S. [Combination therapy in arterial hypertension: how to personalize treatment]. G Ital Cardiol (Rome). 2025 Jan;26(1 Suppl 2):e23-e31. PMID: 39898751", "BibTeX": "@article{39898751, title={[Combination therapy in arterial hypertension: how to personalize treatment].}, author={Bacca A and Taddei S}, journal={G Ital Cardiol (Rome)}, volume={26}, number={1 Suppl 2}, pages={e23-e31}}"}}, {"_id": "38088116", "pmid": 38088116, "title": "[Efficacy and Organoprotection of Triple Combinations in the Treatment of Arterial Hypertension].", "journal": "Kardiologiia", "authors": ["Serdechnaya EV"], "date": "2023-12-05T00:00:00Z", "doi": "10.18087/cardio.2023.11.n2582", "meta_date_publication": "2023 Dec 5", "meta_volume": "63", "meta_issue": "11", "meta_pages": "80-86", "score": 50270.41, "text_hl": "[Efficacy and Organoprotection of Triple Combinations in the Treatment of @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@Arterial Hypertension@@@].", "citations": {"NLM": "Serdechnaya EV. [Efficacy and Organoprotection of Triple Combinations in the Treatment of Arterial Hypertension]. Kardiologiia. 2023 Dec 5;63(11):80-86. PMID: 38088116", "BibTeX": "@article{38088116, title={[Efficacy and Organoprotection of Triple Combinations in the Treatment of Arterial Hypertension].}, author={Serdechnaya EV}, journal={Kardiologiia}, volume={63}, number={11}, pages={80-86}}"}}, {"_id": "36837543", "pmid": 36837543, "pmcid": "PMC9962722", "title": "Opportunities of Amlodipine as a Potential Candidate in the Evaluation of Drug Compliance during Antihypertensive Therapy", "journal": "Medicina (Kaunas)", "authors": ["Kustovs D", "Urtāne I", "Sevostjanovs E", "Moreino E", "Trušinskis K"], "date": "2023-02-10T00:00:00Z", "doi": "10.3390/medicina59020340", "meta_date_publication": "2023 Feb 10", "meta_volume": "59", "meta_issue": "2", "meta_pages": "", "score": 50265.375, "text_hl": "To control @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@arterial hypertension@@@, 70 (86.4%) @SPECIES_9606 @@@patients@@@ used fixed-dose combinations, where one of the components was @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@. ", "citations": {"NLM": "Kustovs D, Urtāne I, Sevostjanovs E, Moreino E, Trušinskis K. Opportunities of Amlodipine as a Potential Candidate in the Evaluation of Drug Compliance during Antihypertensive Therapy Medicina (Kaunas). 2023 Feb 10;59(2):. PMID: 36837543", "BibTeX": "@article{36837543, title={Opportunities of Amlodipine as a Potential Candidate in the Evaluation of Drug Compliance during Antihypertensive Therapy}, author={Kustovs D and Urtāne I and Sevostjanovs E and Moreino E and Trušinskis K}, journal={Medicina (Kaunas)}, volume={59}, number={2}}"}}, {"_id": "33849417", "pmid": 33849417, "title": "Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin.", "journal": "Kardiologiia", "authors": ["Agarkov NM", "Okhotnikov OI", "Korneeva SI", "Moskaleva EO", "Moskalev AA", "Kolomiets VI", "Markelova AM", "Markelova EA"], "date": "2021-03-30T00:00:00Z", "doi": "10.18087/cardio.2021.3.n1509", "meta_date_publication": "2021 Mar 30", "meta_volume": "61", "meta_issue": "3", "meta_pages": "36-41", "score": 50259.04, "text_hl": "Psychological Continuum of Elderly @SPECIES_9606 @@@Patients@@@ Suffering from @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@Arterial Hypertension@@@ with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@Metabolic Syndrome@@@, Against the Background of Chronotherapy with a Fixed Combination of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, @CHEMICAL_Lisinopril @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@.", "citations": {"NLM": "Agarkov NM, Okhotnikov OI, Korneeva SI, Moskaleva EO, Moskalev AA, Kolomiets VI, Markelova AM, Markelova EA. Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin. Kardiologiia. 2021 Mar 30;61(3):36-41. PMID: 33849417", "BibTeX": "@article{33849417, title={Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin.}, author={Agarkov NM and Okhotnikov OI and Korneeva SI and Moskaleva EO and Moskalev AA and Kolomiets VI and Markelova AM and Markelova EA}, journal={Kardiologiia}, volume={61}, number={3}, pages={36-41}}"}}, {"_id": "33550755", "pmid": 33550755, "title": "[The effect of antihypertensive chronotherapy on indicators of the daily blood pressure profile in elderly patients with arterial hypertension with a history of myocardial infarction.]", "journal": "Adv Gerontol", "authors": ["Agarkov NM", "Proschayev KI", "Lutay YA", "Ilnitskiy AN", "Korneeva SI", "Markelova AM", "Kolomiets VI"], "date": "2020-01-01T00:00:00Z", "meta_date_publication": "2020", "meta_volume": "33", "meta_issue": "5", "meta_pages": "972-976", "score": 50257.727, "text_hl": "[The effect of antihypertensive chronotherapy on indicators of the daily blood pressure profile in elderly @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@arterial hypertension@@@ with a history of @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@.]", "citations": {"NLM": "Agarkov NM, Proschayev KI, Lutay YA, Ilnitskiy AN, Korneeva SI, Markelova AM, Kolomiets VI. [The effect of antihypertensive chronotherapy on indicators of the daily blood pressure profile in elderly patients with arterial hypertension with a history of myocardial infarction.] Adv Gerontol. 2020;33(5):972-976. PMID: 33550755", "BibTeX": "@article{33550755, title={[The effect of antihypertensive chronotherapy on indicators of the daily blood pressure profile in elderly patients with arterial hypertension with a history of myocardial infarction.]}, author={Agarkov NM and Proschayev KI and Lutay YA and Ilnitskiy AN and Korneeva SI and Markelova AM and Kolomiets VI}, journal={Adv Gerontol}, volume={33}, number={5}, pages={972-976}}"}}, {"_id": "35640871", "pmid": 35640871, "title": "Comparative Efficacy of Antihypertensive Drugs in Dogs: A Systematic Review.", "journal": "Top Companion Anim Med", "authors": ["Choi HI", "Kim J", "Shin IS", "Kim HJ"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.tcam.2022.100674", "meta_date_publication": "2022 Sep-Oct", "meta_volume": "50", "meta_issue": "", "meta_pages": "100674", "score": 50255.55, "text_hl": "The study included 75 @SPECIES_9615 @@@dogs@@@ diagnosed with @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@systemic arterial hypertension@@@ (systolic blood pressure >=150 mmHg). ", "citations": {"NLM": "Choi HI, Kim J, Shin IS, Kim HJ. Comparative Efficacy of Antihypertensive Drugs in Dogs: A Systematic Review. Top Companion Anim Med. 2022 Sep-Oct;50():100674. PMID: 35640871", "BibTeX": "@article{35640871, title={Comparative Efficacy of Antihypertensive Drugs in Dogs: A Systematic Review.}, author={Choi HI and Kim J and Shin IS and Kim HJ}, journal={Top Companion Anim Med}, volume={50}, pages={100674}}"}}, {"_id": "34549689", "pmid": 34549689, "title": "[Vasoprotective effects hypotensive therapy in patients with coronary heart disease combined with chronic kidney disease stage 2-3 after coronary stenting].", "journal": "Kardiologiia", "authors": ["Pribylova NN", "Yakovleva MV", "Pribylov CA", "Barbashina TA", "Gavriljuk EV", "Mal GS", "Pribylov VS"], "date": "2021-08-31T00:00:00Z", "doi": "10.18087/cardio.2021.8.n1525", "meta_date_publication": "2021 Aug 31", "meta_volume": "61", "meta_issue": "8", "meta_pages": "14-22", "score": 50253.617, "text_hl": "The use of @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ following stenting exerted the most significant angioprotective and cardioprotective effect.Conclusion      @SPECIES_9606 @@@Patients@@@ with @DISEASE_Myocardial_Ischemia @DISEASE_MESH:D017202 @@@IHD@@@ and @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@AH@@@ in combination with early @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@CKD@@@ have pronounced impairment of the condition of arterial blood vessels and the heart. ", "citations": {"NLM": "Pribylova NN, Yakovleva MV, Pribylov CA, Barbashina TA, Gavriljuk EV, Mal GS, Pribylov VS. [Vasoprotective effects hypotensive therapy in patients with coronary heart disease combined with chronic kidney disease stage 2-3 after coronary stenting]. Kardiologiia. 2021 Aug 31;61(8):14-22. PMID: 34549689", "BibTeX": "@article{34549689, title={[Vasoprotective effects hypotensive therapy in patients with coronary heart disease combined with chronic kidney disease stage 2-3 after coronary stenting].}, author={Pribylova NN and Yakovleva MV and Pribylov CA and Barbashina TA and Gavriljuk EV and Mal GS and Pribylov VS}, journal={Kardiologiia}, volume={61}, number={8}, pages={14-22}}"}}, {"_id": "35578761", "pmid": 35578761, "pmcid": "PMC9170320", "title": "Use of single pill combinations in the treatment of arterial hypertension in Poland: The current practice and guidelines, the impact on reimbursement spending and patient co-payment", "journal": "Cardiol J", "authors": ["Czech M", "Boguslawski S", "Smaga A", "Filipiak KJ"], "date": "2022-01-01T00:00:00Z", "doi": "10.5603/CJ.a2022.0031", "meta_date_publication": "2022", "meta_volume": "29", "meta_issue": "3", "meta_pages": "405-412", "score": 50249.824, "text_hl": "The potential of switching from @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@AH@@@ treatment in the analyzed period using monocomponent drugs with the equivalent SPC amounted to 19% of unit volume (a reduction of 212M units), with the highest switch potential (43.9%) for drugs containing @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@. ", "citations": {"NLM": "Czech M, Boguslawski S, Smaga A, Filipiak KJ. Use of single pill combinations in the treatment of arterial hypertension in Poland: The current practice and guidelines, the impact on reimbursement spending and patient co-payment Cardiol J. 2022;29(3):405-412. PMID: 35578761", "BibTeX": "@article{35578761, title={Use of single pill combinations in the treatment of arterial hypertension in Poland: The current practice and guidelines, the impact on reimbursement spending and patient co-payment}, author={Czech M and Boguslawski S and Smaga A and Filipiak KJ}, journal={Cardiol J}, volume={29}, number={3}, pages={405-412}}"}}]}